FDA finally issues geriatric labeling rules

Washington Notebook

WASHINGTON - FDA last week unveiled a final rule on geriatric labeling of prescription drugs and biologics, nearly seven years after the agency first proposed regulations to establish a "precautions" subsection of the label on the use of drugs in elderly or geriatric patients.

According to the agency, the rule is necessary because of the special

Read the full 582 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE